RTP biotechnology firm begins human trials for potential COVID-19 treatment

Research Triangle Park-based BioCryst will conduct trials to see if its experimental yellow fever drug is effective against COVID-19.

Powered by WPeMatico

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.